O'Connell, Ryan M. and Chaudhuri, Aadel A. and Rao, Dinesh S. and Gibson, William S. J. and Balazs, Alejandro B. and Baltimore, David (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proceedings of the National Academy of Sciences of the United States of America, 107 (32). pp. 14235-14240. ISSN 0027-8424 http://resolver.caltech.edu/CaltechAUTHORS:20100913-113144776
![[img]](http://authors.library.caltech.edu/style/images/fileicons/application_pdf.png)
|
PDF
- Published Version
See Usage Policy. 1075Kb | |
|
PDF
- Supplemental Material
See Usage Policy. 733Kb | |
![[img]](http://authors.library.caltech.edu/style/images/fileicons/application_msword.png) |
MS Word
- Supplemental Material
See Usage Policy. 535Kb | |
|
MS Word
- Supplemental Material
See Usage Policy. 49Kb |
Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:20100913-113144776
Abstract
The production of blood cells depends on a rare hematopoietic stem-cell (HSC) population, but the molecular mechanisms underlying HSC biology remain incompletely understood. Here, we identify a subset of microRNAs (miRNAs) that is enriched in HSCs compared with other bone-marrow cells. An in vivo gain-of-function screen found that three of these miRNAs conferred a competitive advantage to engrafting hematopoietic cells, whereas other HSC miRNAs attenuated production of blood cells. Overexpression of the most advantageous miRNA, miR-125b, caused a dose-dependent myeloproliferative disorder that progressed to a lethal myeloid leukemia in mice and also enhanced hematopoietic engraftment in human immune system mice. Our study identifies an evolutionarily conserved subset of miRNAs that is expressed in HSCs and functions to modulate hematopoietic output.
| Item Type: | Article | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Information: | © 2010 by the National Academy of Sciences. Contributed by David Baltimore, July 7, 2010 (sent for review June 25, 2010). We thank the Caltech FACS core facility for their assistance with cell sorting. R.M.O. was funded in part by the Irvington Institute Fellowship Program of the Cancer Research Institute and by Award K99HL102228 from the National Heart, Lung, and Blood Institute. A.A.C. was funded by the Graduate Research Fellowship Program of the National Science Foundation. D.S.R. was funded by Award 1K08CA133521 from the National Cancer Institute. A.B.B. is supported by American Foundation for AIDS Research (amfAR) fellowship #107756-47-RFVA. This work was also supported by National Institutes of Health Grant 1R01AI079243-01. Author contributions: R.M.O., A.A.C., D.S.R., W.S.J.G., A.B.B., and D.B. designed research; R.M.O., A.A.C., D.S.R., and W.S.J.G. performed research; R.M.O. and A.A.C. contributed new reagents/analytic tools; R.M.O., A.A.C., D.S.R., W.S.J.G., A.B.B., and D.B. analyzed data; and R.M.O., A.A.C., and D.B. wrote the paper. Conflict of interest statement: The authors declare that they have no competing financial interests except for D.B., who is a scientific advisor to Regulus Therapeutics, a company devoted to microRNA therapeutics. R.M.O and A.A.C. contributed equally to this work. | ||||||||||||||
| Funders: |
| ||||||||||||||
| Subject Keywords: | cancer; inflammation; myeloid; xenograft; noncoding RNA | ||||||||||||||
| Record Number: | CaltechAUTHORS:20100913-113144776 | ||||||||||||||
| Persistent URL: | http://resolver.caltech.edu/CaltechAUTHORS:20100913-113144776 | ||||||||||||||
| Related URLs: | |||||||||||||||
| Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||||||||||
| ID Code: | 19908 | ||||||||||||||
| Collection: | CaltechAUTHORS | ||||||||||||||
| Deposited By: | Tony Diaz | ||||||||||||||
| Deposited On: | 15 Sep 2010 21:42 | ||||||||||||||
| Last Modified: | 26 Dec 2012 12:25 |
Repository Staff Only: item control page
